Ranmal, S;
Tuleu, C;
(2013)
Demonstrating evidence of acceptability: The "Catch-22" of pediatric formulation development.
Clinical Pharmacology and Therapeutics
, 94
(5)
582 - 584.
10.1038/clpt.2013.154.
![[thumbnail of clpt2013154a.pdf]](https://discovery.ucl.ac.uk/style/images/fileicons/application_pdf.png) Preview |
PDF
clpt2013154a.pdf Download (171kB) |
Abstract
Both researchers and practitioners have reached an influential period in the new era of developing pediatric medicines. Evolving regulatory reforms and guidance continue to serve as platforms steering research and development while distinctive opportunities and challenges in the field emerge. An advancing research need involves gaining a better understanding of end-user requirements and acceptability of formulations. This review considers solid oral forms to demonstrate the importance of such research to stakeholders in policy and practice. © 2013 American Society for Clinical Pharmacology and Therapeutics.
| Type: | Article |
|---|---|
| Title: | Demonstrating evidence of acceptability: The "Catch-22" of pediatric formulation development |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1038/clpt.2013.154 |
| Publisher version: | http://dx.doi.org/10.1038/clpt.2013.154 |
| Additional information: | © 2013 American Society for Clinical Pharmacology and Therapeutics. This work is licensed under a Creative Commons Attribution-NonCommercial-No Derivative Works 3.0 License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ |
| UCL classification: | UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy > Pharmaceutics |
| URI: | https://discovery.ucl.ac.uk/id/eprint/1433797 |
Archive Staff Only
 |
View Item |
